Page last updated: 2024-08-21

dihydroergotamine and methyldopa

dihydroergotamine has been researched along with methyldopa in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bissada, NK; Finkbeiner, AE; Welch, LT	1
Conté, JJ; Fournié, GJ; Maurette, MH	1

Reviews

1 review(s) available for dihydroergotamine and methyldopa

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for dihydroergotamine and methyldopa

Article	Year
Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted). Cardiology, 1976, Volume: 61 suppl 1 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bethanidine; Blood Pressure; Clinical Trials as Topic; Dihydroergotamine; Ergotamines; Female; Guanidines; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Methyldopa; Middle Aged; Posture	1976

Article

Year

Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted).

Cardiology, 1976, Volume: 61 suppl 1

Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bethanidine; Blood Pressure; Clinical Trials as Topic; Dihydroergotamine; Ergotamines; Female; Guanidines; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Methyldopa; Middle Aged; Posture

1976

Other Studies

4 other study(ies) available for dihydroergotamine and methyldopa

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Uropharmacology: XI. Adrenergic-blocking agents and drugs affecting catecholamine binding and release. Urology, 1979, Volume: 13, Issue:6 Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bretylium Compounds; Dihydroergotamine; Guanethidine; Humans; Male; Methyldopa; Muscle, Smooth; Phenoxybenzamine; Phentolamine; Propranolol; Urethra; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Tract; Urination Disorders	1979